Observational studyRadiation oncology (London, England)2020

1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.

Filippo Alongi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.